Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nypro was a leading contract manufacturer specializing in precision plastic injection molding and device development for the healthcare industry, particularly medical devices, diagnostics, and drug delivery. It was acquired by Jabil in 2013. As part of Jabil Healthcare, its clinical and manufacturing capabilities continue to serve global pharma and medtech clients across commercial and clinical portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nypro.